Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Year-over-year debt growth rate
Latest
-12.45%
↓ 251% vs avg
Percentile
P18
Within normal range
Streak
3 qtr
Consecutive declineDecelerating
Average
-3.55%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -12.45% |
| Q3 2025 | -0.27% |
| Q2 2025 | -0.04% |
| Q1 2025 | 1.84% |
| Q4 2024 | -0.44% |
| Q3 2024 | -0.17% |
| Q2 2024 | -0.28% |
| Q1 2024 | -0.13% |
| Q4 2023 | -0.36% |
| Q3 2023 | 0.21% |
| Q2 2023 | -0.11% |
| Q1 2023 | 46.16% |
| Q4 2022 | -2.87% |
| Q3 2022 | 20.02% |
| Q2 2022 | -6.55% |
| Q1 2022 | 24.79% |
| Q4 2021 | -6.74% |
| Q3 2021 | -6.18% |
| Q2 2021 | -5.73% |
| Q1 2021 | -5.19% |
| Q4 2020 | -4.90% |
| Q3 2020 | -4.68% |
| Q2 2020 | 23.50% |
| Q1 2020 | -3.85% |
| Q4 2019 | -5.00% |
| Q3 2019 | 27.04% |
| Q2 2019 | -5.10% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | -77.24% |
| Q3 2017 | -43.17% |
| Q2 2017 | -29.77% |
| Q1 2017 | -2.95% |
| Q4 2016 | -23.85% |
| Q3 2016 | -15.19% |
| Q2 2016 | -12.98% |
| Q1 2016 | 90.78% |